Gland Pharma News

Gland Pharma Q1 Results: Net Profit Surges 50% YoY to Rs 215.4 Cr; Revenue Rises 7.4%, EBITDA Jumps 39%

Gland Pharma Q1 Results: Net Profit Surges 50% YoY to Rs 215.4 Cr; Revenue Rises 7.4%, EBITDA Jumps 39%

Gland Pharma Q4 Results 2025: Profit Dips 3% YoY to Rs 187 Crore, EBITDA Down 3%, 1800% Dividend Announced

Gland Pharma Q4 Results 2025: Profit Dips 3% YoY to Rs 187 Crore, EBITDA Down 3%, 1800% Dividend Announced

Gland Pharma Q4 Results 2025 Preview: Steady Growth Expected on Strong US Sales, New Launches; Share Price Up

Gland Pharma Q4 Results 2025 Preview: Steady Growth Expected on Strong US Sales, New Launches; Share Price Up

Rs 20 Dividend: Record Date After Independence Day; Target Potential Rs 2640 & 3000; Buy With A SL of Rs 1900?

Rs 20 Dividend: Record Date After Independence Day; Target Potential Rs 2640 & 3000; Buy With A SL of Rs 1900?

Motilal Oswal Assigns Buy On 11 Stocks From Healthcare Sector, Sees Robust Gains In 2023

Motilal Oswal Assigns Buy On 11 Stocks From Healthcare Sector, Sees Robust Gains In 2023

New Low: Stocks That Hit Their New Year's 52-Week Low, Shed Over 57% In 1-Year

New Low: Stocks That Hit Their New Year's 52-Week Low, Shed Over 57% In 1-Year

Sharekhan Assigns Buy To Mid Cap Stock, Downgrades Small Cap Stock To Hold

Sharekhan Assigns Buy To Mid Cap Stock, Downgrades Small Cap Stock To Hold

Motilal Oswal Tuesday Stock Ideas: Buy 5 Mid Cap, Small Cap Stocks To Get Up To 46% Return

Motilal Oswal Tuesday Stock Ideas: Buy 5 Mid Cap, Small Cap Stocks To Get Up To 46% Return

This Midcap Pharma Stock Trading 7% Up From 52 Week Low, Buy For Robust 40% Gains: Motilal Oswal

This Midcap Pharma Stock Trading 7% Up From 52 Week Low, Buy For Robust 40% Gains: Motilal Oswal

Buy This Pharma Stock, Trading 2% Away From 52-Week Low, For 57% Gain: Motilal Oswal

Buy This Pharma Stock, Trading 2% Away From 52-Week Low, For 57% Gain: Motilal Oswal

Stocks To Hold: Axis Securities Assigns Hold Rating To Small Cap, Mid Cap Stocks

Stocks To Hold: Axis Securities Assigns Hold Rating To Small Cap, Mid Cap Stocks

Share Of This Pharma Stock Registers Biggest Intra-Day Loss, Hits Fresh 52-Week Low

Share Of This Pharma Stock Registers Biggest Intra-Day Loss, Hits Fresh 52-Week Low

5 Stocks That Hit New 52-Week Low As Market Volatility Persists

5 Stocks That Hit New 52-Week Low As Market Volatility Persists

7 High-Quality Stocks That Have Plunged To 52-Week Lows

7 High-Quality Stocks That Have Plunged To 52-Week Lows

Buy Large Cap Pharma Stock For Over 40 Gains, Sees 24% Earnings CAGR, Stock Near 52 Week Low

Buy Large Cap Pharma Stock For Over 40 Gains, Sees 24% Earnings CAGR, Stock Near 52 Week Low

Buy This Pharma Stock For High Returns, Company's India Sales Up Sharply By 137%: Motilal Oswal

Buy This Pharma Stock For High Returns, Company's India Sales Up Sharply By 137%: Motilal Oswal

This Pharma Stock Can Gain Up To 21% In The Short Term

This Pharma Stock Can Gain Up To 21% In The Short Term

Divis Lab, Abbott, Gland Pharma Hit Fresh 52-Week High As Nifty Pharma Witnesses Breakout

Divis Lab, Abbott, Gland Pharma Hit Fresh 52-Week High As Nifty Pharma Witnesses Breakout

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+